These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 31133049)

  • 21. Preparation of Diphtheria and Pseudomonas Exotoxin A Immunotoxins and Evaluation of Their Cytotoxicity Effect on SK-BR-3, BT-474, and MDA-MB-231 Breast Cancer Cell Lines.
    Amoozadeh S; Hemmati M; Farajollahi MM; Akbari N; Tarighi P
    Cancer Invest; 2019; 37(10):546-557. PubMed ID: 31597492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.
    Weldon JE; Pastan I
    FEBS J; 2011 Dec; 278(23):4683-700. PubMed ID: 21585657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunoconjugate of anti-CD24 and Pseudomonas exotoxin selectively kills human colorectal tumors in mice.
    Shapira S; Shapira A; Starr A; Kazanov D; Kraus S; Benhar I; Arber N
    Gastroenterology; 2011 Mar; 140(3):935-46. PubMed ID: 21147107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.
    Yu X; Dobrikov M; Keir ST; Gromeier M; Pastan IH; Reisfeld R; Bigner DD; Chandramohan V
    PLoS One; 2019; 14(1):e0210608. PubMed ID: 30625226
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Leshem Y; Pastan I
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30621280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of a recombinant immunotoxin against the human granulocyte-colony stimulating factor receptor.
    Babavalian E; Zeinoddini M; Saeedinia AR; Mohammadi R; Xodadadi N
    Mol Biol Rep; 2019 Feb; 46(1):1093-1097. PubMed ID: 30565075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery, synthesis of novel fusidic acid derivatives possessed amino-terminal groups at the 3-hydroxyl position with anticancer activity.
    Ni J; Guo M; Cao Y; Lei L; Liu K; Wang B; Lu F; Zhai R; Gao X; Yan C; Wang H; Bi Y
    Eur J Med Chem; 2019 Jan; 162():122-131. PubMed ID: 30445262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moxetumomab Pasudotox: First Global Approval.
    Dhillon S
    Drugs; 2018 Nov; 78(16):1763-1767. PubMed ID: 30357593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and characterization of the recombinant immunotoxin RTA-4D5-KDEL targeting HER2/neu-positive cancer cells and locating the endoplasmic reticulum.
    Jiao P; Zhang J; Dong Y; Wei D; Ren Y
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9585-9594. PubMed ID: 30141083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting PRPK Function Blocks Colon Cancer Metastasis.
    Zykova T; Zhu F; Wang L; Li H; Lim DY; Yao K; Roh E; Yoon SP; Kim HG; Bae KB; Wen W; Shin SH; Nadas J; Li Y; Ma W; Bode AM; Dong Z
    Mol Cancer Ther; 2018 May; 17(5):1101-1113. PubMed ID: 29483219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathway.
    Liu XF; Zhou Q; Hassan R; Pastan I
    Oncotarget; 2017 Oct; 8(50):87307-87316. PubMed ID: 29152082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview.
    Polito L; Djemil A; Bortolotti M
    Biomedicines; 2016 Jun; 4(2):. PubMed ID: 28536379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of antiviral immunotoxins.
    Spiess K; Jakobsen MH; Kledal TN; Rosenkilde MM
    J Leukoc Biol; 2016 Jun; 99(6):911-25. PubMed ID: 26729815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A.
    Weldon JE; Skarzynski M; Therres JA; Ostovitz JR; Zhou H; Kreitman RJ; Pastan I
    Bioconjug Chem; 2015 Jun; 26(6):1120-8. PubMed ID: 25997032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.
    Lamb R; Ozsvari B; Lisanti CL; Tanowitz HB; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2015 Mar; 6(7):4569-84. PubMed ID: 25625193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in anticancer immunotoxin therapy.
    Alewine C; Hassan R; Pastan I
    Oncologist; 2015 Feb; 20(2):176-85. PubMed ID: 25561510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125.
    Hassan R; Sharon E; Thomas A; Zhang J; Ling A; Miettinen M; Kreitman RJ; Steinberg SM; Hollevoet K; Pastan I
    Cancer; 2014 Nov; 120(21):3311-9. PubMed ID: 24989332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected low-dose toxicity of the universal solvent DMSO.
    Galvao J; Davis B; Tilley M; Normando E; Duchen MR; Cordeiro MF
    FASEB J; 2014 Mar; 28(3):1317-30. PubMed ID: 24327606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotoxins: the role of the toxin.
    Antignani A; Fitzgerald D
    Toxins (Basel); 2013 Aug; 5(8):1486-502. PubMed ID: 23965432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells.
    Kalghatgi S; Spina CS; Costello JC; Liesa M; Morones-Ramirez JR; Slomovic S; Molina A; Shirihai OS; Collins JJ
    Sci Transl Med; 2013 Jul; 5(192):192ra85. PubMed ID: 23825301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.